Healthy potentially undervalued

Results

2459

Companies which are potentially undervalued and in an acceptable financial position.

2459 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	EMBLA	DKK 26.50	-0.7%	-20.4%	DKK 11.3b	DKK 33.30	20.2	11.9%	0%	Healthcare
	VTURA	NOK 29.90	0.7%	63.8%	NOK 3.1b	NOK 42.42	3.3	9.1%	n/a	Energy
	CADLR	NOK 52.75	-1.3%	0.09%	NOK 20.3b	NOK 70.36	6.8	14.4%	n/a	Capital Goods
	AVIA	Rp312.00	-6.0%	-27.4%	Rp18.3t	Rp510.80	10.2	5.8%	7.1%	Materials
	TLKM	Rp2,520.00	-14.0%	-2.3%	Rp255.1t	Rp3,628.86	15.0	11.5%	8.4%	Telecom
	OIL	₹422.55	1.3%	-10.5%	₹680.2b	₹531.10	10.4	7.9%	2.7%	Energy
	LKQ	US$25.41	-2.8%	-32.0%	US$6.6b	US$40.81	12.6	14.4%	4.7%	Retail
	SAM	US$177.61	-2.8%	-10.2%	US$1.8b	US$230.39	0.9	38.4%	n/a	Food, Beverage & Tobacco
	INSP	US$41.35	0.5%	-68.2%	US$1.2b	US$52.17	9.1	-14.0%	n/a	Healthcare
	QGEN	US$36.28	-2.0%	-26.2%	US$7.6b	US$43.82	18.7	12.4%	6.6%	Pharmaceuticals & Biotech
	ARJO B	SEK 24.30	0.4%	-28.1%	SEK 6.5b	SEK 30.00	18.9	21.3%	3.9%	Healthcare
	EGLA	€0.99	-5.8%	-53.6%	€165.9m	€1.23	0.2	100.8%	4.2%	Capital Goods
	PHM	€68.75	0.7%	-13.1%	€1.2b	€106.11	14.8	31.7%	1.2%	Pharmaceuticals & Biotech
	FGR	€129.95	0.9%	14.7%	€12.4b	€161.21	12.1	7.3%	3.7%	Capital Goods
	INF	€38.60	1.6%	-1.3%	€256.8m	€51.24	16.4	13.4%	5.2%	Software
	ADUS	US$95.03	0.2%	-15.9%	US$1.7b	US$132.69	17.4	11.1%	n/a	Healthcare
	TRLV	US$9.12	-7.5%	178.9%	US$1.9b	US$19.42	1.5	124.5%	n/a	Pharmaceuticals & Biotech
	ATMU	US$52.12	4.2%	47.1%	US$4.2b	US$66.40	20.2	10.9%	0.4%	Capital Goods
	PCZ	€8.44	0.7%	-6.4%	€505.3m	€14.73	0.5	20.9%	5.6%	Banks
	ICG	UK£17.44	-2.9%	-8.7%	UK£4.8b	UK£24.21	10.1	10.4%	5.0%	Diversified Financials
	FLOC	US$23.06	-2.3%	31.4%	US$2.1b	US$31.56	22.6	37.4%	1.6%	Energy
	WAY	US$17.31	-6.7%	-54.1%	US$3.5b	US$33.83	26.3	19.9%	n/a	Healthcare
	CEVI	SEK 135.80	-7.5%	-26.3%	SEK 3.3b	SEK 179.00	24.2	15.0%	2.0%	Healthcare
	CABKA	€1.98	-3.9%	1.0%	€49.9m	€3.28	0.3	105.5%	0%	Materials

Page 1 of 69